Goldman Sachs Starts Ecolab Inc. (ECL) at Neutral
Get Alerts ECL Hot Sheet
Price: $276.11 -0.05%
Rating Summary:
26 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
26 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs resumed coverage Ecolab Inc. (NYSE: ECL) with a Neutral rating and $61 price target.
The firm said while investors are warming up to the strategic rationale of the Nalco takeover, the deal does introduce greater volatility to Ecolab's earnings stream based on Nalco's history.
With its history of consistency, impressive shareholder returns, expectations for mid-teens EPS growth, and a well-regarded management team, the firm expects the company to retain its position as one of the most respected and highly valued chemical companies. They would become more bullish on a pull back or we they saw a case for more aggressive EPS growth.
For an analyst ratings summary and ratings history on Ecolab Inc. click here. For more ratings news on Ecolab Inc. click here.
Shares of Ecolab Inc. closed at $55.62 yesterday.
The firm said while investors are warming up to the strategic rationale of the Nalco takeover, the deal does introduce greater volatility to Ecolab's earnings stream based on Nalco's history.
With its history of consistency, impressive shareholder returns, expectations for mid-teens EPS growth, and a well-regarded management team, the firm expects the company to retain its position as one of the most respected and highly valued chemical companies. They would become more bullish on a pull back or we they saw a case for more aggressive EPS growth.
For an analyst ratings summary and ratings history on Ecolab Inc. click here. For more ratings news on Ecolab Inc. click here.
Shares of Ecolab Inc. closed at $55.62 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
New CoverageRelated Entities
Goldman Sachs, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share